Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
Christine Katlama, Robert MurphyPierre et Marie Curie Université – Paris 6, Service de Maladies Infectieuses et Tropicales, Paris, FranceAbstract: Integrase is an essential HIV-1-specific enzyme that is an active target for antiretroviral drug development. Recently, a new class...
Saved in:
Main Authors: | Christine Katlama (Author), Robert Murphy (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
by: Linda A. Mandikiyana Chirimuta, et al.
Published: (2022) -
Raltegravir: first in class HIV integrase inhibitor
by: Zelalem Temesgen, et al.
Published: (2008) -
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
by: Emma G. Foster, et al.
Published: (2022) -
Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China
by: Yu F, et al.
Published: (2022) -
Effect of switching to integrase inhibitor on the HIV reservoir in ileum biopsies
by: S. Moron-Lopez, et al.
Published: (2017)